Neurogene Inc. Quarterly Depreciation, Depletion and Amortization in USD from Q1 2013 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.
Summary
Neurogene Inc. quarterly/annual Depreciation, Depletion and Amortization history and growth rate from Q1 2013 to Q2 2025.
  • Neurogene Inc. Depreciation, Depletion and Amortization for the quarter ending June 30, 2025 was $800K, unchanged year-over-year.
  • Neurogene Inc. Depreciation, Depletion and Amortization for the twelve months ending June 30, 2025 was $3.13M, a 4.11% decline year-over-year.
  • Neurogene Inc. annual Depreciation, Depletion and Amortization for 2024 was $3.2M, a 2.05% decline from 2023.
  • Neurogene Inc. annual Depreciation, Depletion and Amortization for 2023 was $3.26M, a 2.07% increase from 2022.
  • Neurogene Inc. annual Depreciation, Depletion and Amortization for 2022 was $3.2M, a 145% increase from 2021.
Depreciation, Depletion and Amortization, Trailing 12 Months (USD)
Depreciation, Depletion and Amortization, Quarterly (USD)
Depreciation, Depletion and Amortization, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 $3.13M $800K $0 0% Apr 1, 2025 Jun 30, 2025 10-Q 2025-08-11
Q1 2025 $3.13M $749K -$65K -7.99% Jan 1, 2025 Mar 31, 2025 10-Q 2025-05-09
Q4 2024 $3.2M $781K -$69K -8.12% Oct 1, 2024 Dec 31, 2024 10-K 2025-03-24
Q3 2024 $3.26M $800K $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-18
Q2 2024 $3.26M $800K $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2025-08-11
Q1 2024 $3.26M $814K +$2K +0.25% Jan 1, 2024 Mar 31, 2024 10-Q 2025-05-09
Q4 2023 $3.26M $850K Oct 1, 2023 Dec 31, 2023 10-K 2025-03-24
Q3 2023 $800K Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-18
Q2 2023 $800K Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-09
Q1 2023 $812K +$401K +97.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-10
Q1 2022 $411K +$164K +66.4% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-08
Q1 2021 $247K +$76K +44.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q1 2020 $171K +$130K +317% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-12
Q1 2019 $41K Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-06
Q2 2014 $71.9K +$56.3K +361% Mar 29, 2014 Jun 30, 2014 10-Q 2014-08-11
Q1 2014 $18.2K +$3.45K +23.4% Jan 1, 2014 Mar 31, 2014 10-Q 2014-05-13
Q2 2013 $15.6K Apr 1, 2013 Jun 30, 2013 10-Q 2014-08-11
Q1 2013 $14.8K Jan 1, 2013 Mar 31, 2013 10-Q 2014-05-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.